Position in PFE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$13,756,566
-$2,800,356 QoQ
Shares Held
571,286
-3.1% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#356
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GAMCO INVESTORS, INC. ET AL holds $86,182,010 across 9 Drug Manufacturers - General names. PFE ranks #3 (16.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
27,377 | $32,836,797 | |
| 2 | JNJ |
Johnson & Johnson
|
80,050 | $20,330,298 | |
| 3 | PFE |
Pfizer Inc
This page
|
571,286 | $13,756,566 | |
| 4 | MRK |
Merck & Co., Inc.
|
62,672 | $8,053,352 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
82,671 | $4,763,503 | |
| 6 | ABBV |
AbbVie Inc.
|
13,603 | $3,423,058 | |
| 7 | AMGN |
Amgen Inc
|
4,618 | $1,672,270 | |
| 8 | OGN |
Organon & Co.
|
86,872 | $1,176,246 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,756,566 | 571,286 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $16,556,922 | 589,634 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $14,450,241 | 580,331 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $14,352,985 | 563,304 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $16,270,881 | 671,241 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $20,118,338 | 793,936 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $20,305,106 | 765,364 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $19,613,882 | 677,743 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $16,247,006 | 580,665 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $14,797,715 | 533,251 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $6,855,244 | 238,112 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,081,809 | 153,205 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $5,641,384 | 153,800 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $6,430,732 | 157,616 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $8,442,251 | 164,759 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $7,825,557 | 178,829 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $10,516,147 | 200,575 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $9,975,975 | 192,698 | Shares | Sole | 2022-05-18 | |
| 2021-12-31 | $11,551,774 | 195,627 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $8,826,426 | 205,218 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $8,276,544 | 211,352 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $6,954,529 | 191,955 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $7,287,570 | 197,978 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $7,956,809 | 216,807 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $7,712,204 | 235,847 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $9,895,912 | 303,184 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||